Chapter 10 · The Vicious Cycle
How insulin resistance drives fatty liver — and how fasting breaks the loop

The lab results came back on a Tuesday morning, and they answered a question Mark hadn't known he was asking until the numbers appeared on his screen.
Dr. Nguyen had ordered the standard liver panel — ALT, AST, GGT, platelets — as planned for his follow-up. But she'd also added two tests Mark had requested at his last appointment: fasting insulin and HOMA-IR. He'd read about them in one of the papers Dave had sent. Liver enzymes told you what the liver was doing. Insulin markers told you why.
"I want to understand how insulin-resistant I actually am," he'd told Dr. Nguyen. "Not just the liver symptoms. The root cause."
She'd nodded and ordered the tests without hesitation — a doctor who appreciated patients who wanted to understand their own biology.
Now Mark was sitting at his desk at work, staring at the results on his phone:
Fasting glucose: 98 mg/dL (normal range: under 100) Fasting insulin: 18 mIU/L (normal range: 2–5) HOMA-IR: 4.1 (normal: under 2)
His glucose was technically normal. Ninety-eight. Just under the wire. The kind of number a doctor might glance at and say "fine."
But the insulin told a different story. Eighteen. Three and a half times the upper limit of normal. His pancreas was producing insulin at a rate that belonged to someone whose cells had stopped listening — because that's exactly what had happened. His cells had stopped listening. And his pancreas was compensating by screaming louder.
HOMA-IR — the Homeostatic Model Assessment for Insulin Resistance — synthesized both numbers into a single score. Below 2 was normal. Between 2 and 4 was moderate resistance. Above 4 was severe.
Mark was at 4.1. Severe.
He set the phone down on his desk and looked out the window. Austin in late morning, the light hard and flat against the office building across the street. The number sat in his mind like a stone dropped into water, the ripples spreading outward, touching everything.
This was the real problem.
Not the fat in his liver. The fat was a symptom. The real problem was that his cells — his liver cells, his muscle cells, his fat tissue — had stopped responding properly to insulin's signal. They were resistant. And his pancreas, sensing that the signal wasn't getting through, was pumping out more and more insulin, trying to force the message past the resistance.
His body was caught in a loop. And the loop had been running, undetected, for years.
That evening, after the kids were in bed and the house was quiet, Mark opened his laptop at the kitchen table and pulled up a paper he'd saved weeks ago: Insulin Resistance and Non-Alcoholic Fatty Liver Disease: Mechanisms and Clinical Implications. He'd skimmed it before. Tonight he read it like a map of his own body.

The mechanism was laid out in steps, each one feeding the next:
Chronic overnutrition — years of eating more than he needed, not dramatically, not grotesquely, but consistently. Late-night snacks. Second helpings. Conference lunches. Reward food after long days. Nothing extreme on its own. In aggregate: a slow, sustained surplus that his body had been processing for years.
That surplus meant chronically elevated glucose and insulin. His pancreas, doing its job, released insulin after every meal, every snack, every handful of trail mix at 10 PM. The signal was constant: Blood sugar is high. Store energy. Store it now.
Over months and years, the constant hammering of that signal desensitized his cells. The insulin receptor — a protein sitting on the surface of every hepatocyte, every muscle cell — started responding less vigorously. Same signal, weaker response. Like a door that's been knocked on so relentlessly that the people inside stop getting up to answer it.
As his liver cells became resistant, something paradoxical happened. The liver, confused by high insulin it couldn't properly interpret, defaulted to fat storage. De novo lipogenesis — the creation of new triglycerides from carbohydrates — ramped up. The liver's own fat reserves grew. This was MASLD.
And then the fat itself made things worse. Accumulated hepatic fat triggered inflammatory pathways. Inflammation damaged insulin signaling further. The liver became more resistant. The pancreas, sensing that its signal still wasn't working, produced even more insulin. Hyperinsulinemia.
The high insulin — even though the liver and muscles weren't hearing it properly — still reached one tissue loud and clear: adipose tissue. Fat cells, especially visceral fat cells around the organs and midsection, were exquisitely sensitive to insulin. They heard the signal and expanded. They stored energy. Mark's weight crept up, concentrated around his middle — the visceral fat that was metabolically the most dangerous kind.
And the visceral fat produced inflammatory cytokines. TNF-alpha. IL-6. Molecules that entered the bloodstream and made every other tissue more insulin-resistant.
More resistance. More insulin. More fat. More inflammation. More resistance.
The loop.
Mark stared at the diagram he'd drawn in his notes app — ten steps, each arrow pointing to the next, the last arrow curving back to the beginning. A circle with no exit. A machine that, once started, accelerated itself.
Without intervention, this loop would have continued until his pancreas burned out trying to keep up — type 2 diabetes. Until his liver progressed from fat accumulation to inflammation to fibrosis — MASH. Until the metabolic dysfunction was severe enough to require medications, or multiple medications, or worse.
He texted Dave: "My fasting insulin is 18. HOMA-IR is 4.1. Textbook severe insulin resistance. How did I not know this was happening?"
"Because nobody tells you. Doctors see the pattern, they say 'lose weight, eat better' and move on. They don't explain the mechanism. But you've been living inside it for years without understanding it."
"So everything makes sense now."
"Everything makes sense now."
Mark closed the text thread and sat with the understanding for a while. The kitchen was dark except for the laptop screen. Biscuit was asleep on the couch. Somewhere in the house, a pipe ticked — the old-house sound that usually irritated him but tonight felt companionable, like the house was thinking alongside him.
Something was crystallizing. Something he'd been circling for weeks without landing on.
He'd spent months believing that his liver problem was about food. About eating too much, eating wrong, being undisciplined. The guilt had been ambient and constant — every meal carried a faint charge of self-judgment. Should I be eating this? Is this making it worse? Am I failing?
But the mechanism wasn't about food quantity. It was about hormonal timing.
He pulled up the comparison he'd been thinking about and typed it out:
Person A eats 2,200 calories across six eating occasions — breakfast, morning snack, lunch, afternoon snack, dinner, evening snack. Six insulin spikes per day. Average fasting insulin: 12. Time spent with elevated insulin: 18+ hours. The liver is in storage mode almost continuously.
Person B eats 2,200 calories across two meals — lunch and dinner, within an 8-hour window. Two insulin spikes per day. Average fasting insulin: 6. Time spent with elevated insulin: 4 hours. The liver gets 16 hours of metabolic recovery.
Same calories. Half the insulin exposure. Seventy-five percent less time in the hormonal state that drives fat storage.
This was why fasting worked. Not because Mark was eating fewer calories — he wasn't, not meaningfully. He was eating the same amount during his eating window as he'd eaten daily before. The difference was that his insulin was low for sixteen hours per day instead of high for twenty. The low-insulin periods gave his liver a break. Gave his cells a chance to recover sensitivity. Gave the whole system a window to stop storing and start mobilizing.
He wasn't fasting to deprive himself. He was fasting to interrupt the signal.
He texted Dave one more time: "So fasting isn't about restriction. It's about hormonal reset."
"Exactly. Calories are half the picture. The other half is timing and what it does to insulin."
"Everything I've read about just cutting calories was incomplete."
"Medicine caught up. That's why NAFLD is MASLD now — metabolic dysfunction is the issue, not just being overweight. The fix is metabolic, not just caloric."
Mark closed his laptop and sat in the dark kitchen. Forty-nine consecutive days of fasting. Week seven. He'd been on 16:8 for two weeks now, and the experience was no longer novel — it was just how he ate. Close the kitchen at 6 PM. Open it at 10 AM. The hunger that had once dominated his mornings had become a faint, manageable background signal that passed by hour twelve.
His appointment with Dr. Nguyen was tomorrow. He wanted to know: had his insulin started dropping? Had his HOMA-IR improved?
Probably not dramatically. Seven weeks was good, but insulin sensitivity recovery sometimes took months. The adaptation was gradual — cellular receptors slowly upregulating, inflammatory markers slowly declining, the pancreas slowly easing off its compensatory overdrive.
But the mechanism made sense now. Every sixteen-hour fast was a metabolic reset. Every low-insulin window was a recovery period. Every day he stayed consistent, his liver cells were getting a chance to remember what it felt like to respond to insulin normally — to stop hoarding fat and start mobilizing it.
He was breaking the loop.
Not all at once. Not in a single dramatic intervention. But one sixteen-hour window at a time, the vicious cycle was losing momentum. The arrows in his diagram were getting weaker. The circle was starting to crack.
Fatty liver disease affects 38% of adults globally. Learn what MASLD is, why the name changed from NAFLD, and what you can do about it.